Literature DB >> 22158621

Exposing a hidden functional site of C-reactive protein by site-directed mutagenesis.

Sanjay K Singh1, Avinash Thirumalai, David J Hammond, Michael K Pangburn, Vinod K Mishra, David A Johnson, Antonio E Rusiñol, Alok Agrawal.   

Abstract

C-reactive protein (CRP) is a cyclic pentameric protein whose major binding specificity, at physiological pH, is for substances bearing exposed phosphocholine moieties. Another pentameric form of CRP, which exists at acidic pH, displays binding activity for oxidized LDL (ox-LDL). The ox-LDL-binding site in CRP, which is hidden at physiological pH, is exposed by acidic pH-induced structural changes in pentameric CRP. The aim of this study was to expose the hidden ox-LDL-binding site of CRP by site-directed mutagenesis and to generate a CRP mutant that can bind to ox-LDL without the requirement of acidic pH. Mutation of Glu(42), an amino acid that participates in intersubunit interactions in the CRP pentamer and is buried, to Gln resulted in a CRP mutant (E42Q) that showed significant binding activity for ox-LDL at physiological pH. For maximal binding to ox-LDL, E42Q CRP required a pH much less acidic than that required by wild-type CRP. At any given pH, E42Q CRP was more efficient than wild-type CRP in binding to ox-LDL. Like wild-type CRP, E42Q CRP remained pentameric at acidic pH. Also, E42Q CRP was more efficient than wild-type CRP in binding to several other deposited, conformationally altered proteins. The E42Q CRP mutant provides a tool to investigate the functions of CRP in defined animal models of inflammatory diseases including atherosclerosis because wild-type CRP requires acidic pH to bind to deposited, conformationally altered proteins, including ox-LDL, and available animal models may not have sufficient acidosis or other possible modifiers of the pentameric structure of CRP at the sites of inflammation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22158621      PMCID: PMC3271008          DOI: 10.1074/jbc.M111.310011

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  63 in total

Review 1.  Molecular chaperones in protein folding and proteostasis.

Authors:  F Ulrich Hartl; Andreas Bracher; Manajit Hayer-Hartl
Journal:  Nature       Date:  2011-07-20       Impact factor: 49.962

Review 2.  Does an acidic pH explain why low density lipoprotein is oxidised in atherosclerotic lesions?

Authors:  D S Leake
Journal:  Atherosclerosis       Date:  1997-03-21       Impact factor: 5.162

3.  No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/human C-reactive protein transgenic mice.

Authors:  A Trion; M P M de Maat; J W Jukema; A van der Laarse; M C Maas; E H Offerman; L M Havekes; A J Szalai; H M G Princen; J J Emeis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-05-26       Impact factor: 8.311

Review 4.  The protective function of human C-reactive protein in mouse models of Streptococcus pneumoniae infection.

Authors:  Alok Agrawal; Madathilparambil V Suresh; Sanjay K Singh; Donald A Ferguson
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-12       Impact factor: 2.895

5.  C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids.

Authors:  Mi-Kyung Chang; Christoph J Binder; Michael Torzewski; Joseph L Witztum
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-20       Impact factor: 11.205

6.  Relationship between ion pair geometries and electrostatic strengths in proteins.

Authors:  Sandeep Kumar; Ruth Nussinov
Journal:  Biophys J       Date:  2002-09       Impact factor: 4.033

7.  No effect of C-reactive protein on early atherosclerosis in LDLR-/- / human C-reactive protein transgenic mice.

Authors:  Michael Torzewski; Kurt Reifenberg; Fei Cheng; Elena Wiese; Ines Küpper; Jeanine Crain; Karl J Lackner; Sucharit Bhakdi
Journal:  Thromb Haemost       Date:  2008-01       Impact factor: 5.249

8.  Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia.

Authors:  Alexander Kovacs; Per Tornvall; Roland Nilsson; Jesper Tegnér; Anders Hamsten; Johan Björkegren
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-16       Impact factor: 11.205

9.  Lack of effect of a single injection of human C-reactive protein on murine lupus or nephrotoxic nephritis.

Authors:  Francesco Carlucci; H Terence Cook; Abhilok Garg; Mark B Pepys; Marina Botto
Journal:  Arthritis Rheum       Date:  2010-01

10.  Studies of acute phase protein. I. An immunohistochemical method for the localization of Cx-reactive protein in rabbits. Association with necrosis in local inflammatory lesions.

Authors:  I KUSHNER; M H KAPLAN
Journal:  J Exp Med       Date:  1961-12-01       Impact factor: 14.307

View more
  22 in total

1.  Functional Transformation of C-reactive Protein by Hydrogen Peroxide.

Authors:  Sanjay K Singh; Avinash Thirumalai; Asmita Pathak; Donald N Ngwa; Alok Agrawal
Journal:  J Biol Chem       Date:  2017-01-17       Impact factor: 5.157

2.  C-reactive protein protects mice against pneumococcal infection via both phosphocholine-dependent and phosphocholine-independent mechanisms.

Authors:  Toh B Gang; Gregory A Hanley; Alok Agrawal
Journal:  Infect Immun       Date:  2015-02-17       Impact factor: 3.441

3.  Structurally Altered, Not Wild-Type, Pentameric C-Reactive Protein Inhibits Formation of Amyloid-β Fibrils.

Authors:  Donald N Ngwa; Alok Agrawal
Journal:  J Immunol       Date:  2022-08-17       Impact factor: 5.426

4.  Computational analysis of C-reactive protein for assessment of molecular dynamics and interaction properties.

Authors:  Chiranjib Chakraborty; Alok Agrawal
Journal:  Cell Biochem Biophys       Date:  2013-11       Impact factor: 2.194

5.  Probing the phosphocholine-binding site of human C-reactive protein by site-directed mutagenesis.

Authors:  A Agrawal; Y Xu; D Ansardi; K J Macon; J E Volanakis
Journal:  J Biol Chem       Date:  1992-12-15       Impact factor: 5.157

6.  The phosphocholine-binding pocket on C-reactive protein is necessary for initial protection of mice against pneumococcal infection.

Authors:  Toh B Gang; David J Hammond; Sanjay K Singh; Donald A Ferguson; Vinod K Mishra; Alok Agrawal
Journal:  J Biol Chem       Date:  2012-11-08       Impact factor: 5.157

7.  Factor H-related protein 5 interacts with pentraxin 3 and the extracellular matrix and modulates complement activation.

Authors:  Ádám I Csincsi; Anne Kopp; Miklós Zöldi; Zsófia Bánlaki; Barbara Uzonyi; Mario Hebecker; Joseph J E Caesar; Matthew C Pickering; Kenji Daigo; Takao Hamakubo; Susan M Lea; Elena Goicoechea de Jorge; Mihály Józsi
Journal:  J Immunol       Date:  2015-04-08       Impact factor: 5.422

Review 8.  Pentraxins: structure, function, and role in inflammation.

Authors:  Terry W Du Clos
Journal:  ISRN Inflamm       Date:  2013-09-14

9.  A significant correlation between C - reactive protein levels in blood monocytes derived macrophages versus content in carotid atherosclerotic lesions.

Authors:  Marielle Kaplan; Shadi Hamoud; Yevgeny Tendler; Edna Meilin; Aviva Lazarovitch; Samy Nitecki; Tony Hayek
Journal:  J Inflamm (Lond)       Date:  2014-03-03       Impact factor: 4.981

Review 10.  Recognition functions of pentameric C-reactive protein in cardiovascular disease.

Authors:  Alok Agrawal; Toh B Gang; Antonio E Rusiñol
Journal:  Mediators Inflamm       Date:  2014-05-19       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.